KPTI
Price
$4.24
Change
+$0.04 (+0.95%)
Updated
Jun 2, 04:24 PM (EDT)
Capitalization
36.29M
XNCR
Price
$8.49
Change
+$0.49 (+6.12%)
Updated
Jun 2, 04:44 PM (EDT)
Capitalization
569.37M
58 days until earnings call
Interact to see
Advertisement

KPTI vs XNCR

Header iconKPTI vs XNCR Comparison
Open Charts KPTI vs XNCRBanner chart's image
Karyopharm Therapeutics
Price$4.24
Change+$0.04 (+0.95%)
Volume$200
Capitalization36.29M
Xencor
Price$8.49
Change+$0.49 (+6.12%)
Volume$2.61K
Capitalization569.37M
KPTI vs XNCR Comparison Chart
Loading...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPTI vs. XNCR commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPTI is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (KPTI: $4.20 vs. XNCR: $8.00)
Brand notoriety: KPTI and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPTI: 98% vs. XNCR: 132%
Market capitalization -- KPTI: $36.29M vs. XNCR: $569.37M
KPTI [@Biotechnology] is valued at $36.29M. XNCR’s [@Biotechnology] market capitalization is $569.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPTI’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • KPTI’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both KPTI and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPTI’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • KPTI’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than KPTI.

Price Growth

KPTI (@Biotechnology) experienced а -8.50% price change this week, while XNCR (@Biotechnology) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +3.07%, and the average quarterly price growth was -0.47%.

Reported Earning Dates

KPTI is expected to report earnings on May 13, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($569M) has a higher market cap than KPTI($36.3M). KPTI YTD gains are higher at: -58.598 vs. XNCR (-65.187). KPTI has higher annual earnings (EBITDA): -38.6M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. KPTI (109M). XNCR has less debt than KPTI: XNCR (67.8M) vs KPTI (195M). KPTI has higher revenues than XNCR: KPTI (145M) vs XNCR (127M).
KPTIXNCRKPTI / XNCR
Capitalization36.3M569M6%
EBITDA-38.6M-161.68M24%
Gain YTD-58.598-65.18790%
P/E RatioN/AN/A-
Revenue145M127M114%
Total Cash109M470M23%
Total Debt195M67.8M288%
FUNDAMENTALS RATINGS
KPTI vs XNCR: Fundamental Ratings
KPTI
XNCR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
9696
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/a48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (4) in the Biotechnology industry is significantly better than the same rating for XNCR (78). This means that KPTI’s stock grew significantly faster than XNCR’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XNCR (100). This means that KPTI’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (94) in the Biotechnology industry is in the same range as KPTI (100). This means that XNCR’s stock grew similarly to KPTI’s over the last 12 months.

XNCR's Price Growth Rating (96) in the Biotechnology industry is in the same range as KPTI (96). This means that XNCR’s stock grew similarly to KPTI’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for KPTI (100). This means that XNCR’s stock grew significantly faster than KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPTIXNCR
RSI
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 27 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSIQ10.530.19
+1.84%
Canadian Solar
MFC31.840.10
+0.32%
Manulife Financial Corp
FNB13.87-0.15
-1.07%
FNB Corp
LVTX1.31-0.02
-1.13%
LAVA Therapeutics NV
XOMA24.76-0.74
-2.90%
XOMA Royalty Corporation

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with MGNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
-7.28%
MGNX - KPTI
38%
Loosely correlated
-2.86%
XNCR - KPTI
36%
Loosely correlated
+3.43%
ARRY - KPTI
35%
Loosely correlated
-0.30%
NTLA - KPTI
34%
Loosely correlated
-7.79%
FATE - KPTI
34%
Loosely correlated
-8.33%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+3.43%
CRNX - XNCR
58%
Loosely correlated
-0.03%
BEAM - XNCR
56%
Loosely correlated
-3.00%
ERAS - XNCR
55%
Loosely correlated
-3.45%
ACLX - XNCR
54%
Loosely correlated
-2.54%
KRYS - XNCR
53%
Loosely correlated
+0.28%
More